Transcatheter Aortic Valve Implantation (TAVI) Market Research, 2030 Depending on procedure, the transfemoral, segment dominated the market in 2020, and this trend is expected to continue during the ...

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

Caranx Medical ("Caranx"), a French medical device company specializing in the development of an autonomous robot to democratize access to Transcatheter Aortic Valve Implantation (TAVI), a lifesaving ...

RATES of permanent pacemaker implantation (PPI) exceed 20% in patients with aortic regurgitation (AR). A new retrospective ...

TAVIPILOT Soft is said to be a ‘world-first’ provision for real-time surgical guidance during TAVI and TAVR procedures.

Jaipur's Rajasthan Hospital achieved a medical milestone by replacing a heart valve non-surgically through the arm artery.

A nationwide analysis of Spanish data reveals an increase in the risk for permanent pacemaker implantation following transcatheter aortic valve implantation from 2017 to 2022.

Dapagliflozin reduced the risk of all-cause mortality or worsening heart failure by 28% in patients with aortic stenosis ...

Five people in the East of England have become the first to benefit from a pioneering treatment for heart valve disease at ...

The FDA has granted 510(k) clearance to the TaviPilot AI software developed by Caranx Medical, according to company officials ...

MiRus announced new early feasibility study results supporting the use of its Siegel transcatheter aortic valve replacement ...

Patients received a new treatment for heart valve disease, which did not require riskier open-heart surgery or travel to London. Five people from Cambridgeshire, Essex, Hertfordshire, Peterborough and ...